Sterigmatocystin
Overview[edit]

Sterigmatocystin is a mycotoxin produced by certain species of fungi, particularly those belonging to the genus Aspergillus. It is a precursor to aflatoxin, one of the most potent carcinogens known. Sterigmatocystin is commonly found in cereal grains, coffee, and other agricultural products that are susceptible to fungal contamination.
Chemical Structure[edit]
Sterigmatocystin is a polyketide compound with a complex molecular structure. It is characterized by a dioxin ring system and multiple hydroxyl groups, which contribute to its toxicity. The chemical formula of sterigmatocystin is C18H12O6.
Biosynthesis[edit]
The biosynthesis of sterigmatocystin involves a series of enzymatic reactions that convert simple carbon sources into the complex polyketide structure. This process is regulated by a cluster of genes that encode the necessary enzymes for each step of the pathway. The final product, sterigmatocystin, can be further converted into aflatoxin by additional enzymatic modifications.
Health Effects[edit]
Sterigmatocystin is known to be hepatotoxic, meaning it can cause damage to the liver. It is also classified as a potential carcinogen, with studies showing its ability to induce tumors in laboratory animals. Human exposure to sterigmatocystin is primarily through the consumption of contaminated food products.
Detection and Control[edit]
The detection of sterigmatocystin in food and feed is typically performed using chromatographic techniques such as HPLC and mass spectrometry. To control contamination, it is important to implement good agricultural practices and storage conditions that minimize fungal growth. Additionally, regulatory agencies set maximum allowable levels of mycotoxins in food products to protect public health.
Related Pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian